Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
how does imatinib work in cml | 0.16 | 0.5 | 488 | 64 |
how does imatinib work | 1.49 | 0.2 | 3910 | 34 |
imatinib resistance in cml | 1.97 | 0.3 | 9556 | 31 |
cml imatinib causes low blood level | 1.55 | 0.9 | 3477 | 99 |
imatinib dose for cml | 1.53 | 0.4 | 6456 | 17 |
imatinib cml side effects | 1.78 | 0.7 | 2456 | 15 |
when was imatinib approved for cml | 0.72 | 0.3 | 955 | 62 |
what does imatinib do | 0.4 | 0.8 | 3486 | 91 |
imatinib in chronic myeloid leukaemia | 0.1 | 0.7 | 2695 | 32 |
imatinib chronic myeloid leukemia | 0.74 | 0.2 | 9648 | 34 |
imatinib mechanism of action | 0.58 | 0.6 | 2875 | 99 |
imatinib mode of action | 0.11 | 0.8 | 9378 | 66 |
imatinib mesylate mechanism of action | 1.15 | 0.9 | 1989 | 64 |
what does imatinib treat | 0.44 | 0.2 | 7367 | 81 |
imatinib cml oxford protocol | 1.67 | 0.9 | 3147 | 32 |
how is imatinib administered | 1.2 | 0.9 | 550 | 2 |
clinical pharmacokinetics of imatinib | 1.38 | 0.3 | 3097 | 29 |
imatinib route of administration | 0.9 | 0.4 | 7827 | 65 |
imatinib therapeutic drug monitoring | 1.05 | 0.4 | 761 | 54 |
can imatinib be crushed | 1.06 | 0.8 | 1600 | 43 |
is imatinib mesylate chemotherapy | 1.25 | 0.4 | 2352 | 57 |